Hybio Pharmaceutical Co., Ltd.(XSEC:300199) added to S&P Global BMI Index
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.22 CNY | -0.39% | -16.84% | -24.74% |
05-29 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
05-29 | Hybio Pharmaceutical Grants Commercial Rights of Weight Loss Drug to Sansheng Mandi Pharmaceutical | MT |
1st Jan change | Capi. | |
---|---|---|
-24.74% | 1.25B | |
+18.09% | 41.07B | |
+22.12% | 22.65B | |
+15.71% | 15.02B | |
+20.11% | 14.14B | |
+52.15% | 12.09B | |
-11.59% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.59B |
- Stock Market
- Equities
- 300199 Stock
- News Hybio Pharmaceutical Co., Ltd.
- Hybio Pharmaceutical Co., Ltd.(XSEC: 300199) added to S&P Global BMI Index